The relationship between factor V Leiden or prothrombin G20210A mutations and arterial thrombosis remains uncertain, complicating long-term treatment decisions for recurrent thrombosis.
No takes yet. Share an insight, caveat, or question.
Uncertainty persists in attributing recurrent thrombosis to factor V Leiden; case reports leave open whether genetic testing guides anticoagulation duration.
Mira et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: